K. Blyth (Glasgow (Glasgow), United Kingdom), M. Pereira Catarata (Porto, Portugal)
Using InfraRed (IR) Spectroscopy to differentiate between Mesothelioma (Meso), Other Malignant & Non-Malignant pleural effusions
L. Fox (Portsmouth, United Kingdom), S. Glaysher (Portsmouth, United Kingdom), A. Hicks (Portsmouth, United Kingdom), M. Ball (Portsmouth, United Kingdom), R. Asciak (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. D'Cruz (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom)
|   |
BAP1 loss in the diagnosis of malignant mesothelioma; review of a regional mesothelioma MDT
H. Mcdill (Bristol (Avon), United Kingdom), A. Dipper (Bristol (Avon), United Kingdom), N. Bhatt (Bristol (Avon), United Kingdom), A. Clive (Bristol (Avon), United Kingdom), N. Maskell (Bristol (Avon), United Kingdom), A. Bibby (Bristol (Avon), United Kingdom)
| |
The Management of Thymoma - a retrospective cohort analysis
R. Cooper (Stoke-on-Trent, United Kingdom), M. Adil (Stoke-on-Trent, United Kingdom), M. Ganaie (Stoke-on-Trent, United Kingdom)
| |
Diagnostic value of the cancer ratio in pleural effusion – a retrospective study
M. Cavaco (Lisbon, Portugal), L. Mateus (Lisbon, Portugal), A. Nunes (Lisbon, Portugal), R. Cordeiro (Lisbon, Portugal), C. Silvestre (Lisbon, Portugal), J. Ferra (Lisbon, Portugal), D. Duarte (Lisbon, Portugal), C. Cardoso (Lisbon, Portugal), P. Raimundo (Lisbon, Portugal), A. Domingos (Lisbon, Portugal)
| |
Has the impact of the COVID-19 pandemic on uptake and usage of indwelling pleural catheters reduced its cost-effectiveness?
D. Li (Leicester, United Kingdom), S. Johnstone (Leicester, United Kingdom), P. Parthasarathy (Leicester, United Kingdom), R. Sudhir (Leicester, United Kingdom), M. Tufail (Leicester, United Kingdom), R. Panchal (Leicester, United Kingdom)
| |
Malignant Pleural Effusion and Auto-pleurodesis: Biomarkers, Predictors and Survival
D. Addala (Oxford, United Kingdom), Y. Soo (Oxford, United Kingdom), A. Sundaralingam (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), B. Iqbal (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |
Molecular identification of the primary cilium BBSome complex in pleural mesothelial cells
E. Rouka (Larissa, Greece), R. Jagirdar (Larissa, Greece), E. Pitaraki (Larissa, Greece), O. Kotsiou (Larissa, Greece), C. Hatzoglou (Larissa, Greece), K. Gourgoulianis (Larissa, Greece), S. Zarogiannis (Larissa, Greece)
| |
Human malignant pleural mesothelioma derived pleura fluid induces mesenchymal transition of benign pleural mesothelial cells
R. Jagirdar (Larisa, Greece), E. Rouka (Larisa, Greece), E. Pitaraki (Larisa, Greece), O. Kotsiou (Larisa, Greece), C. Hatzoglou (Larisa, Greece), K. Gourgoulianis (Larisa, Greece), S. Zarogiannis (Larisa, Greece)
| |
Diagnosis and management of thymomas in the Covid-19 era
C. Cheung (Basildon, United Kingdom), R. D'Espiney (Basildon, United Kingdom), E. Capuano (Basildon, United Kingdom), B. Yung (Basildon, United Kingdom)
| |
Mortality among hospitalized patients with pleural effusions.
E. MARKATIS (Corfu, Greece), G. Perlepe (Larissa, Greece), A. Afhtinos (Corfu, Greece), K. Pagkratis (Corfu, Greece), C. Varsamas (Larissa, Greece), E. Chaini (Corfu, Greece), I. Papanikolaou (Corfu, Greece), K. Gourgoulianis (Larissa, Greece)
| |
MicroRNAs shuttled by extracellular vesicles within pleural fluids promote lung cancer cell proliferation
S. Taverna (Palermo (PA), Italy), G. Cammarata (Palermo (PA), Italy), A. Masucci (Palermo (PA), Italy), I. Giusti (Palermo (PA), Italy), V. Dolo (Palermo (PA), Italy), E. Pace (Palermo (PA), Italy), E. Pace (Palermo (PA), Italy)
| |
Changes in the primary diagnosis of malignant pleural effusion
O. Karcioglu (Ankara, Turkey), F. Tekin (Ankara, Turkey), S. Önder (Ankara, Turkey), Z. Selçuk (Ankara, Turkey)
| |
An Evaluation of optimal pleural fluid volume required for accurate cytological diagnosis of malignancy
N. Hussain (Watford, United Kingdom), A. Navarra (Watford, United Kingdom), A. Maddox (Watford, United Kingdom), R. Mogal (Watford, United Kingdom), A. Navarra (Harlow, United Kingdom)
| |
Molecular profiling in Pleural Biopsies
A. Sundaralingam (Oxford, United Kingdom), A. Aujayeb (North Shields, United Kingdom), B. Akca (Vienna, Austria), C. Tiedeman (Newcastle, Australia), V. George (Newcastle, Australia), M. Carling (North Shields, United Kingdom), J. Brown (Oxford, United Kingdom), R. Banka (Mumbai, India), D. Addala (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), B. Iqbal (Oxford, United Kingdom), P. Denniston (Oxford, United Kingdom), M. Tsakok (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), F. Vafai-Tabrizi (Vienna, Austria), M. Bergmann (Vienna, Austria), G. Funk (Vienna, Austria), R. Benamore (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |